T. Roskams's Profile

Role	Title	Level	Year	L/R
🐜	EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. 15 auth. J. Llovet, M. Ducreux, R. Lencioni, A. Bisceglie, P. Galle, J. Dufour, T. Greten, E. Raymond, T. Roskams, T. Baère, ... V. Mazzaferro, M. Bernardi, J. Bruix, M. Colombo, A. Zhu	11	2012	11 🐜
🐜	Serum markers detect the presence of liver fibrosis: a cohort study. 10 auth. W. Rosenberg, M. Voelker, R. Thiel, M. Becka, A. Burt, D. Schuppan, ... S. Hubscher, T. Roskams, M. Pinzani, M. Arthur	10	2004	10 🐜
🐜	A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells 13 auth. Ju-Seog Lee, Jeonghoon Heo, L. Libbrecht, I. Chu, P. Kaposi-Novák, D. Calvisi, A. Mikaelyan, L. Roberts, A. Demetris, Zong-tang Sun, ... F. Nevens, T. Roskams, S. Thorgeirsson	9	2006	9 🐜
🐜	Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling 9 auth. Ju-Seog Lee, I. Chu, Jeonghoon Heo, D. Calvisi, Zong-tang Sun, T. Roskams, ... A. Durnez, A. Demetris, S. Thorgeirsson	9	2004	9 🐜
🐜	Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia 35 auth. M. Kojiro, I. Wanless, V. Alves, S. Badve, C. Balabaud, Pierre Bedosa, P. Bhathal, P. Bioulac-Sage, E. Brunt, A. Burt, J. Craig, A. Dhillon, L. Ferrell, S. Geller, Z. Goodman, ... A. Gouw, M. Guido, M. Guindi, P. Hytiroglou, M. Kage, F. Kondo, M. Kudo, G. Lauwers, M. Nakano, V. Paradis, Y. N. Park, A. Quaglia, M. Roncalli, T. Roskams, B. Ruebner, M. Sakamoto, R. Saxena, N. Theise, S. Thung, Dina Taniakos	9	2009	9 🐜
🦁	Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers 27 auth. T. Roskams, N. Theise, C. Balabaud, G. Bhagat, P. Bhathal, P. Bioulac-Sage, E. Brunt, J. Crawford, H. Crosby, V. Desmet, M. Finegold, S. Geller, A. Gouw, P. Hytiroglou, A. Knisely, ... M. Kojiro, J. Lefkowitch, Y. Nakanuma, J. Olynyk, Young Nyun Park, B. Portmann, R. Saxena, P. Scheuer, A. Strain, S. Thung, I. Wanless, A. West	9	2004	9 🦁
🐬	Clinical diagnosis and staging of cholangiocarcinoma B. Blechacz, M. Komuta, T. Roskams, G. Gores	9	2011	9 🐬
🐜	Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease 15 auth. L. Boulter, O. Govaere, T. Bird, S. Radulescu, P. Ramachandran, A. Pellicoro, R. Ridgway, S. S. Seo, B. Spee, N. Rooijen, ... O. Sansom, J. Iredale, S. Lowell, T. Roskams, S. Forbes	9	2012	9 🐜
🐜	Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma 9 auth. T. Luedde, N. Beraza, Vasileios Kotsikoris, G. Loo, Arianna Nenci, R. Vos, ... T. Roskams, C. Trautwein, M. Pasparakis	9	2007	9 🐜
🐜	Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. 12 auth. J. Andersen, B. Spee, B. Blechacz, I. Avital, M. Komuta, A. Barbour, ... E. Conner, M. Gillen, T. Roskams, L. Roberts, V. Factor, S. Thorgeirsson	8	2012	8 🐜
🦁	Liver stem cells and their implication in hepatocellular and cholangiocarcinoma T. Roskams	8	2006	8 🦁
🦁	Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. 9 auth. T. Roskams, Shiqi Yang, A. Koteish, A. Durnez, R. Devos, Xiawen Huang, ... R. Achten, C. Verslype, A. Diehl	8	2003	8 🦁
🐢	Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. D. Cassiman, L. Libbrecht, V. Desmet, C. Denef, T. Roskams	8	2001	8 🐢